Inventor · Paris, FR

Federico Mingozzi

17Patents
3h-index
27Co-inventors
56Inventor score

Filing activity: May 31, 2007 → Apr 25, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US9909142B2 Composition and methods for highly efficient gene transfer using AAV capsid variants Chemistry; Metallurgy 14 Active
US10392632B2 AAV8 vector with enhanced functional activity and methods of use thereof Chemistry; Metallurgy 10 Active
US11339406B2 Acid-alpha glucosidase variants and uses thereof Chemistry; Metallurgy 3 Active
US11421211B2 Acid-alpha glucosidase variants and uses thereof Chemistry; Metallurgy 3 Active
US10471132B2 Treatment of hyperbilirubinemia Chemistry; Metallurgy 2 Active
US10640785B2 Virus vectors for highly efficient transgene delivery Chemistry; Metallurgy 0 Active
US11541131B2 Treatment of glycogen storage disease III Chemistry; Metallurgy 0 Active
US11408899B2 AAV vector and assay for anti-AAV (adeno-associated virus) neutralizing antibodies Physics 0 Active
US11279950B2 Composition and methods for highly efficient gene transfer using AAV capsid variants Chemistry; Metallurgy 0 Active
US11376321B2 Method for removing anti-AAV antibodies from a blood-derived composition Chemistry; Metallurgy 0 Active
US12037362B2 Hybrid recombinant adeno-associated virus serotype between AAV9 and AAVrh74 with reduced liver tropism Chemistry; Metallurgy 0 Active
US9075044B2 Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy Physics 0 Active
US12171843B2 Hybrid regulatory elements Chemistry; Metallurgy 0 Active
US11427836B2 Method for reducing the expression of NKCC1 in a subject Chemistry; Metallurgy 0 Active
US11939590B1 AAV vector compositions and methods for gene transfer to cells, organs and tissues Chemistry; Metallurgy 0 Active
US12305187B2 Acid-alpha glucosidase variants and uses thereof Chemistry; Metallurgy 0 Active
US11559589B2 Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy Physics 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.